US Broker Ratings

ImmunityBio, Inc. (IBRX) Stock Analysis: Exploring a 122% Potential Upside in Biotech Innovation

ImmunityBio, Inc. (NASDAQ: IBRX), a trailblazer in the biotech sector, is capturing investor attention with its focus on cutting-edge immunotherapies aimed at bolstering the body’s immune..

GeneDx Holdings Corp. (WGS) Stock Analysis: Exploring a 149.77% Potential Upside in the Genomics Sector

GeneDx Holdings Corp. (NASDAQ: WGS) is making waves in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $1.75 billion,..

Perrigo Company plc (PRGO) Stock Analysis: Evaluating a Potential 74.90% Upside in the Healthcare Sector

Perrigo Company plc (NYSE: PRGO), a key player in the drug manufacturing industry, offers a compelling opportunity for investors seeking exposure in the healthcare sector. With..

BioCryst Pharmaceuticals (BCRX) Stock Analysis: A 125% Potential Upside Amid Impressive Revenue Growth

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) is capturing the attention of investors with its remarkable revenue growth and a compelling potential upside of 125.40%. As a biotechnology..

ICU Medical, Inc. (ICUI): Investor Outlook Reveals 45.69% Potential Upside

ICU Medical, Inc. (NASDAQ: ICUI), a leader in the healthcare sector, operates within the Medical Instruments & Supplies industry, offering a broad array of products designed..

Scholar Rock Holding Corporation (SRRK): Investor Outlook Reveals 30% Upside Potential in Biotech Sector

Investor interest in the biotechnology sector continues to gain momentum, and Scholar Rock Holding Corporation (NASDAQ: SRRK) stands out with a promising 30.16% potential upside, according..

Catalyst Pharmaceuticals, Inc. (CPRX) Stock Analysis: Exploring a 42.98% Upside Potential

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) stands out in the biotechnology sector with a market capitalization of $2.92 billion. As a company focused on delivering innovative treatments..

Veracyte, Inc. (VCYT) Stock Analysis: 54.40% Potential Upside Beckons Investors

Veracyte, Inc. (NASDAQ: VCYT), a key player in the healthcare sector, operates within the diagnostics and research industry. Headquartered in the biotech hub of South San..

Privia Health Group, Inc. (PRVA) Stock Analysis: Examining a 59.59% Potential Upside in Healthcare

Privia Health Group, Inc. (NASDAQ: PRVA) is garnering significant attention from investors, thanks to an impressive potential upside of nearly 60% based on analyst targets. As..

Organon & Co. (OGN) Stock Analysis: Unpacking the 57.89% Potential Upside for Healthcare Investors

Organon & Co. (NYSE: OGN), a prominent player in the healthcare sector, focuses on providing women’s health solutions and a range of pharmaceutical products across the..

LivaNova PLC (LIVN) Stock Analysis: Exploring a 30% Upside Potential

LivaNova PLC (LIVN), a pioneering name in the healthcare sector, operates within the medical devices industry and is headquartered in London, United Kingdom. With a market..

Arrowhead Pharmaceuticals, Inc. (ARWR) Stock Analysis: Unveiling a 40% Potential Upside in a Promising Biotech Sector

For investors with an appetite for high-growth opportunities in the biotechnology sector, Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) presents an intriguing prospect. With a market capitalization of..

Ardent Health, Inc. (ARDT) Stock Analysis: Exploring a 54% Potential Upside

Ardent Health, Inc. (ARDT), a key player in the healthcare sector, operates within the medical care facilities industry in the United States. With a market capitalization..

PTC Therapeutics, Inc. (PTCT) Stock Analysis: Exploring a 31.78% Potential Upside Amidst Strategic Collaborations

PTC Therapeutics, Inc. (NASDAQ: PTCT), a prominent player in the biotechnology sector, has captured investor attention with its compelling market dynamics and promising pipeline of treatments..

Sotera Health Company (SHC) Stock Analysis: Exploring a 56.60% Potential Upside in the Healthcare Sector

Sotera Health Company (NASDAQ: SHC) stands as a formidable entity within the healthcare sector, specializing in diagnostics and research. With a market capitalization of $3.77 billion,..

Warby Parker Inc. (WRBY) Stock Analysis: Eyeing a Potential 43% Upside

Warby Parker Inc. (NYSE: WRBY), a prominent player in the healthcare sector, has captured investor attention with its innovative approach to eyewear retailing. With a market..

Envista Holdings Corporation (NVST) Stock Analysis: Navigating Market Dynamics with a Potential 18% Upside

Envista Holdings Corporation (NYSE: NVST), a key player in the healthcare sector, particularly within the medical instruments and supplies industry, offers a compelling case for investors..

Metsera, Inc. (MTSR) Stock Analysis: Navigating a Pioneering Path in Biotechnology with a -19.15% Potential Downside

Metsera, Inc. (NASDAQ: MTSR), a clinical-stage biotechnology firm based in New York, is carving a niche in the healthcare sector with its innovative hormone analog peptides..

Ultragenyx Pharmaceutical Inc. (RARE) Stock Analysis: Exploring Its 171.76% Potential Upside

Ultragenyx Pharmaceutical Inc. (RARE), a prominent player in the biotechnology sector, is capturing investor attention with a potential upside of 171.76%. Specializing in the development and..

Cytokinetics, Incorporated (CYTK) Stock Analysis: Healthcare Innovator with a 47% Upside Potential

Cytokinetics, Incorporated (NASDAQ: CYTK) stands out in the biotechnology sector as a leader in the development of innovative muscle activators and inhibitors aimed at tackling severe..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds